NASDAQ: OPCHOption Care Health Inc Stock
$32.31+1.62 (+5.28%)
Updated Apr 30, 2025
OPCH Price
$32.31
Fair Value Price
$45.48
Market Cap
$5.29B
52 Week Low
$21.39
52 Week High
$35.53
P/E
25.64x
P/B
3.92x
P/S
1.12x
PEG
1.7x
Dividend Yield
N/A
Revenue
$5.19B
Earnings
$213.77M
Gross Margin
20%
Operating Margin
6.54%
Profit Margin
4.1%
Debt to Equity
1.45
Operating Cash Flow
$385M
Beta
0.94
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OPCH Overview
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OPCH's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
OPCH
Ranked#9 of 42
Ranked#9 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.88 | A | |
| $12.73 | A | |
| $14.21 | A |
Be the first to know about important OPCH news, forecast changes, insider trades & much more!
OPCH News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OPCH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OPCH ($32.31) is undervalued by 28.96% relative to our estimate of its Fair Value price of $45.48 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
OPCH ($32.31) is significantly undervalued by 28.96% relative to our estimate of its Fair Value price of $45.48 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
OPCH ($32.31) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OPCH due diligence checks available for Premium users.
Valuation
OPCH fair value
Fair Value of OPCH stock based on Discounted Cash Flow (DCF)
Price
$32.31
Fair Value
$45.48
Undervalued by
28.96%
OPCH ($32.31) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OPCH ($32.31) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OPCH ($32.31) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
OPCH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
25.64x
Industry
14.9x
Market
29.18x
OPCH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OPCH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
OPCH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.92x
Industry
4.38x
OPCH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OPCH price to earnings growth (PEG)
For valuing profitable companies with growth potential
OPCH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
OPCH's financial health
Profit margin
Revenue
$1.3B
Net Income
$46.7M
Profit Margin
3.5%
OPCH's Earnings (EBIT) of $339.26M... subscribe to Premium to read more.
Interest Coverage Financials
OPCH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.3B
Liabilities
$2.0B
Debt to equity
1.45
OPCH's short-term assets ($1.10B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OPCH's long-term liabilities ($1.24B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OPCH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OPCH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$7.2M
Investing
-$126.7M
Financing
-$107.3M
OPCH's operating cash flow ($384.96M)... subscribe to Premium to read more.
Debt Coverage Financials
OPCH vs Medical Care Facility Stocks
Option Care Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.